Modifies provisions relating to pharmacy services in hospitals
Impact
If enacted, SB 1251 will significantly impact how hospitals manage and distribute medications. The bill emphasizes a structured approach to medication therapy services by requiring pharmacists to obtain certification for medication therapeutic plan authority. This certification process will ensure pharmacists are adequately qualified to manage complex medication regimens, thus enhancing patient care within hospital settings. Furthermore, the defined roles of medical staff committees in approving protocols will create additional layers of oversight, aiming for improved safety in medication administration.
Summary
Senate Bill 1251 aims to modify existing provisions relating to pharmacy services within hospitals in Missouri. The bill proposes to repeal the prior section 338.165 and establish new guidelines that grant the department of health and senior services exclusive authority over the regulation of pharmacy services in hospitals. This regulatory shift is intended to streamline how these services are overseen, aligning pharmacy practices with modern healthcare delivery requirements and establishing comprehensive medication management protocols.
Contention
The primary points of contention surrounding SB 1251 may stem from the control shift in regulatory authority from individual hospitals to a state-level department. Advocates for the change argue that centralized regulation will foster consistency in pharmacy services across hospitals, while opponents may express concerns regarding increased bureaucratic oversight and the potential diminishment of hospital autonomy in addressing specific patient care needs. The interaction between the new protocols and existing healthcare practices is another area where debate could arise, particularly regarding how changes will be implemented in diverse hospital environments.
Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)